Skip to Main Content

Advertisement

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood
Blood Advances
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Issue Archive

Select Decade

Select Year

Issue

Volume 71, Issue 2

February 1 1988

In this Issue

ARTICLES
RANDOMIZED CONTROLLED TRIAL
CORRESPONDENCE

Table of Contents

ARTICLES

Circulating glycosaminoglycan anticoagulants associated with suramin treatment

MK 3d Horne,CA Stein,RV LaRocca,CE Myers

Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes

JJ Houle,EM Hoffmann,AF Esser

Restriction of cell lysis by homologous complement: II. Protection of erythrocytes against lysis by newly activated complement

JJ Houle,EM Hoffmann,AF Esser

Platelet-agglutinating protein P37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G

FA Siddiqui,EC Lian

Natural history of idiopathic refractory sideroblastic anemia

M Cazzola,G Barosi,PG Gobbi,R Invernizzi,A Riccardi,E Ascari

The polyadenylation site mutation in the alpha-globin gene cluster

SL Thein,RB Wallace,L Pressley,JB Clegg,DJ Weatherall,DR Higgs

Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor

BR Blazar,MB Widmer,CC Soderling,DL Urdal,S Gillis,LL Robison,DA Vallera

Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts

L Coulombel,MH Vuillet,C Leroy,G Tchernia

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

GJ Jr Broze,LA Warren,WF Novotny,DA Higuchi,JJ Girard,JP Miletich

The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors

CW McMillan,SS Shapiro,D Whitehurst,LW Hoyer,AV Rao,J Lazerson

The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases

LM Wiedemann,KK Karhi,MK Shivji,SI Rayter,SM Pegram,G Dowden,D Bevan,A Will,DA Galton,LC Chan

T-cell leukemias with rearrangement of the gamma but not beta T-cell receptor genes

L Foroni,E Matutes,J Foldi,R Morilla,T Rabbitts,L Luzzatto,D Catovsky

Integrated human T-cell leukemia virus II genome in CD8 + T cells from a patient with "atypical" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders

JD Rosenblatt,JV Giorgi,DW Golde,JB Ezra,A Wu,CD Winberg,J Glaspy,W Wachsman,IS Chen

Protein C deficiency resulting from possible double heterozygosity and its response to danazol

RA Gruppo,P Leimer,RB Francis,RA Marlar,E Silberstein

In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3

J Lotem,L Sachs

Clinical factors influencing the efficacy of pooled platelet transfusions

JF Bishop,K McGrath,MM Wolf,JP Matthews,T De Luise,R Holdsworth,K Yuen,M Veale,MG Whiteside,IA Cooper

Factor V is activated and cleaved by platelet calpain: comparison with thrombin proteolysis

HN Bradford,A Annamalai,K Doshi,RW Colman

Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34

SD Smith,R Morgan,R Gemmell,MD Amylon,MP Link,C Linker,BK Hecht,R Warnke,BE Glader,F Hecht

Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities

J Whang-Peng,RC Young,EC Lee,DL Longo,GP Schechter,VT Jr DeVita

Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA

M Carlsson,TH Totterman,P Matsson,K Nilsson

Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines

GB Faguet,KL Satya-Prakash,JF Agee

Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony- stimulating factor

WE Fibbe,J van Damme,A Billiau,HM Goselink,PJ Voogt,G van Eeden,P Ralph,BW Altrock,JH Falkenburg

Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigen

DF Hayes,H Sekine,D Marcus,CA Alper,DW Kufe

Biosynthesis and processing of lactoferrin in bone marrow cells, a comparison with processing of myeloperoxidase

I Olsson,M Lantz,AM Persson,K Arnljots

The effect of the plasticizer di-2-ethylhexyl phthalate on the survival of stored RBCs

JP AuBuchon,TN Estep,RJ Davey

Plasma cell karyotype in multiple myeloma

J Gould,R Alexanian,A Goodacre,S Pathak,B Hecht,B Barlogie

The Corfu delta beta zero thalassemia: a small deletion acts at a distance to selectively abolish beta globin gene expression [published erratum appears in Blood 1988 May;71(5):1509]

AE Kulozik,N Yarwood,RW Jones

Plasmids in bacteria exposed to activated neutrophils mediate mutagenesis when transferred to new hosts

P De Togni,HB Fox,S Morrissey,LR Tansey,SB Levy,BM Babior

The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene

AE Kulozik,BC Kar,GR Serjeant,BE Serjeant,DJ Weatherall

Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis

K Oshimi,Y Oshimi,M Akahoshi,Y Kobayashi,H Hirai,F Takaku,M Hattori,S Asano,H Kodo,S Nishinarita

An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine

N Yoshida,K Ota,M Moroi,M Matsuda

c-sis but not c-fos gene expression is lineage specific in human myeloid cells

E Sariban,T Mitchell,A Rambaldi,DW Kufe

Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect

AK Rao,J Willis,MA Kowalska,YT Wachtfogel,RW Colman

Evidence for posttranslational control of Hb C synthesis in an individual with Hb C trait and alpha-thalassemia

SA Liebhaber,FE Cash,DB Cornfield

Detection of carriers of the autosomal form of chronic granulomatous disease

AJ Verhoeven,ML van Schaik,D Roos,RS Weening

Spectrin Tunis (alpha I/78): a new alpha I variant that causes asymptomatic hereditary elliptocytosis in the heterozygous state

L Morle,N Alloisio,MT Ducluzeau,B Pothier,R Blibech,R Kastally,J Delaunay

Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease

CR Zerez,NA Lachant,SJ Lee,KR Tanaka

Variation of class I HLA antigen expression among platelet density cohorts: a possible index of platelet age?

J Pereira,C Cretney,RH Aster

Protein co-isolated with human tissue factor impairs recovery of activity

SD Carson,SE Ross,RA Gramzinski

Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization

ST Koury,MC Bondurant,MJ Koury

Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow

Z Hollander,VO Shah,CI Civin,MR Loken

RANDOMIZED CONTROLLED TRIAL

Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials

R Storb,HJ Deeg,L Fisher,F Appelbaum,CD Buckner,W Bensinger,R Clift,K Doney,C Irle,R McGuffin

CORRESPONDENCE

Cell cycle characteristics in acute nonlymphocytic leukemia [letter]

JH Matthews

Front Matter
Table of Contents
Back Matter
Editorial Board

Advertisement

Email alerts

Latest Issue Alert

Latest
Most Read
Most Cited

CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE

STAT5 activation promotes progression and chemotherapy-resistance in early T-cell precursor acute lymphoblastic leukemia

How I Treat Refractory CRS and ICANS Following CAR T-cell Therapy

The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia

Targeting biased signaling by PAR1: Function and molecular mechanism of parmodulins

Advertisement

Advertisement

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright ©2023 by American Society of Hematology

Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement